Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility for image-guided procedures.
-
-
The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers regarding a recent publication that suggests a possible increased risk of death at two years and...
-
Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT Registry to collect and analyze stroke-inducing blood clots removed from the brain with its Embotrap...
-
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study – DISRUPT CAD III – for the use of intravascular lithotripsy (IVL) in...
News | Cardiovascular Ultrasound | January 21, 2019
January 21, 2019 – Medical experts have released “...
Feature | EP Lab | January 21, 2019 | Matthew S. McKillop, M.D., FACC, FHRS, and Seth J. Worley, M.D.
Interventional...
News | Cardiac Diagnostics | January 21, 2019
January 21, 2019 — Meat-free athletes have already proven the performance-boosting power of a plant-based diet. Now...
Sponsored Content
Feature | Sudden Cardiac Arrest | October 25, 2018
Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to...
Technology | Ablation Systems | January 21, 2019
January 21, 2019 — Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force...
This is a 3-D view of blood flow through the chambers of a fetal heart using the GE Healthcare fetalHQ analysis software.
Feature | RSNA | January 17, 2019 | Dave Fornell, Editor
Many of the latest advances in cardiovascular imaging technologies are unveiled each year at the...
Technology | Angiography | January 17, 2019
January 17, 2019 — Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
News | Peripheral Artery Disease (PAD) | January 17, 2019
January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter...
Artificial intelligence in medical imaging was the major buzz at RSNA 2018. The expo floor had a dedicated area just to highlight artificial intelligence software for medical imaging. More than 150 vendors on the expo floor were showing software using some level of AI or deep learning.
Feature | Artificial Intelligence | January 17, 2019 | Dave Fornell, Editor
Artificial intelligence (AI) was by far the hottest trend discussed in sessions and across the expo floor at the...
Sponsored Content | Webinar | Information Technology | January 17, 2019
This ScImage-sponsored ITN/DAIC webinar will be held at 2 p.m. Eastern time, Wednesday, Feb. 6, 2019.
...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
News | Cardiac PACS | January 16, 2019
January 16, 2019 – Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s...
News | Thrombectomy Devices | January 16, 2019
January 16, 2019 — Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT...
News | Cath Lab | January 16, 2019
January 16, 2019 — Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational...
Sponsored Content
An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
News | Structural Heart Occluders | January 16, 2019
January 16, 2019 — Abbott announced the U.S. Food and Drug Administration (FDA) approved the Amplatzer Piccolo...
A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor.
Blog | University of Colorado Hospital | January 16, 2019
In late December, I had the opportunity to conduct an onsite visit to the...
News | Heart Valve Technology | January 15, 2019
January 15, 2019 — Boston Scientific Corp. and Edwards Lifesciences Corp. announced that the companies have reached...
